Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixazomib plus lenalidomide and dexamethasone vs placebo plus lenalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
CTR20130906Phase 3Active
- Sponsor
- Millennium Pharmaceuticals
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ixazomib in multiple myeloma (MM), sponsored by Millennium Pharmaceuticals. Started Mar 2014; status: active.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on CTR20130906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130906.